BioTek Earns Cisbio HTRF Certification

June 26, 2019 BioTek’s Synergy™ Neo2 Hybrid Multi-Mode Microplate Reader received expanded certification from Cisbio Bioassays for their proprietary HTRF® technology, a TR-FRET assay platform used in the Life Sciences. Synergy™ Neo2 was recently updated with an optional TRF laser. The TRF laser provides ultra-fast measurement speed, along with optimal sensitivity for critical screening applications like Time-Resolved Fluorescence (TRF)... Read more

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications BARCELONA, Spain – SLAS EUROPE 2019 – (June 26, 2019) – As the pharmaceutical industry continues to increase its focus on the development of biologics,... Read more

Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier

JUNE 26, 2019 Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier Positions Quanterix to capitalize on significant growth opportunities with Nf-L applications in Alzheimer’s Disease, Multiple Sclerosis, and other neurodegenerative conditions Provides expected 200 bps of annualized company gross margin improvement, before impact of purchase price accounting, and expected to... Read more

QIAGEN and McKesson agree to distribute QIAstat-Dx syndromic testing solution to smaller hospitals and other select segments in the United States

Germantown, Maryland, and Hilden, Germany, June 19, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement for McKesson Medical-Surgical Inc., an affiliate of McKesson Corporation , a global leader in healthcare supply chain management solutions, to serve as the exclusive distributor of QIAGEN’s QIAstat-Dx syndromic testing solution in the “acute” market... Read more

Regulatory Approvals Obtained for the Sale of Brooks' Semiconductor Cryogenics Business to Atlas Copco

Regulatory Approvals Obtained for the Sale of Brooks’ Semiconductor Cryogenics Business to Atlas Copco CHELMSFORD, Mass., June 18, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that all required regulatory approvals, including the approval of the Committee on Foreign Investment in the United States (CFIUS), have been obtained with respect to the sale... Read more

New Scratch Assay Starter Kit Brings Convenience and Reproducibility to Scratch Wound Healing and Invasion Assays

June 14, 2019 BioTek Instruments continues to enhance cell biology workflows with the introduction of the Scratch Assay Starter Kit for use with their Lionheart™ Automated Cell Imagers and Cytation™ Cell Imaging Multi-Mode Readers. The Scratch Assay Starter Kit includes the AutoScratch™ Wound Making Tool, Scratch App software, sample packages of 24- and 96-well microplates, and cleaning reagents. When using this kit in kinetic... Read more

Tecan successfully completes the acquisition of supplier of key parts

Männedorf, Switzerland, May 31, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of a supplier of key parts. On March 22, 2019, Tecan announced the acquisition of a long-term supplier to vertically integrate the manufacturing of critical precision-machined parts. With two manufacturing sites, one in California,... Read more

Brooks to Participate in Two Upcoming Investor Conferences

CHELMSFORD, Mass., May 24, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in two upcoming investor conferences: Jefferies Global Health Care Investor Conference in New York on June 5, 2019 with a presentation at 9:00 a.m. EDT. Stifel Nicholas Cross Sector Insight Conference at the Intercontinental Hotel in Boston... Read more

QIAGEN gains 510(k) clearance by FDA for QIAstat-Dx in the U.S. and launches system as next generation platform for syndromic insights

Germantown, Maryland, and Hilden, Germany, May 20, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its QIAstat-Dx syndromic testing system after receiving 510(k) clearance by the U.S. Food and Drug Administration, along with the multiplex QIAstat-Dx® Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory... Read more